Literature DB >> 3802089

Growth properties of artificial heterogeneous human colon tumors.

J T Leith, S Michelson, L E Faulkner, S F Bliven.   

Abstract

Two clonal cell lines (designated as clones A and D), originally isolated from the heterogeneous DLD-1 human colon adenocarcinoma, were used to produce xenograft tumors in nude mice. Neoplasms produced from either A or D cells alone were compared to those produced from a range of percentage admixtures of the two subpopulations. Then, Gompertzian growth parameters (initial growth rates, retardation rates) were determined, along with estimation of the final asymptotic volumes. It was found that the growth kinetics of the various artificial heterogeneous tumors could not be predicted from knowledge of the growth parameters of the pure clonal xenograft tumors. Additionally, both pure clonal and artificial heterogeneous tumors were enzymatically disaggregated as a function of time postinjection, and it was found that the admixed tumors became more zonal in composition as time progressed. Further, admixtures of extreme composition (i.e., 9% A plus 91% D or 88% A plus 12% D) remained stable with time, while those of intermediate initial composition (i.e., 50% A plus 50% D) did not. All of these data (growth kinetics, zonality, compositional stability) indicate that the growth properties of heterogeneous tumors are very complex.

Entities:  

Mesh:

Year:  1987        PMID: 3802089

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Stochastic models for subpopulation emergence in heterogeneous tumors.

Authors:  S Michelson; K Ito; H T Tran; J T Leith
Journal:  Bull Math Biol       Date:  1989       Impact factor: 1.758

2.  Time-dependent subpopulation induction in heterogeneous tumors.

Authors:  I Gyori; S Michelson; J Leith
Journal:  Bull Math Biol       Date:  1988       Impact factor: 1.758

Review 3.  Cellular interactions in metastasis.

Authors:  F R Miller; G H Heppner
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

4.  Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo.

Authors:  Andrzej Myc; Jolanta Kukowska-Latallo; Peter Cao; Ben Swanson; Julianna Battista; Thomas Dunham; James R Baker
Journal:  Anticancer Drugs       Date:  2010-02       Impact factor: 2.248

5.  Acquisition and enhanced expression of the metastatic phenotype following transfections of genomic mouse tumor DNA containing human SCLC gene sequences.

Authors:  C C Cate; D R Belloni; M Marin-Padilla
Journal:  Clin Exp Metastasis       Date:  1995-05       Impact factor: 5.150

Review 6.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

7.  Autocrine and paracrine growth factors in tumor growth: a mathematical model.

Authors:  S Michelson; J Leith
Journal:  Bull Math Biol       Date:  1991       Impact factor: 1.758

Review 8.  Extracellular Vesicles in Brain Tumor Progression.

Authors:  Esterina D'Asti; Shilpa Chennakrishnaiah; Tae Hoon Lee; Janusz Rak
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

9.  A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression.

Authors:  J Jouanneau; G Moens; Y Bourgeois; M F Poupon; J P Thiery
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

10.  Mixed inocula of mouse mammary tumour cell subpopulations result in changes of organ-specific metastasis.

Authors:  A Hossain; A Sarkar; N H Sarkar
Journal:  Clin Exp Metastasis       Date:  1991 Nov-Dec       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.